ImmunoPrecise Antibodies Ltd (NAS:IPA)
$ 0.7777 -0.0156 (-1.97%) Market Cap: 21.23 Mil Enterprise Value: 28.34 Mil PE Ratio: 0 PB Ratio: 0.85 GF Score: 53/100

Q1 2023 Immunoprecise Antibodies Ltd Earnings Call Transcript

Sep 14, 2022 / 02:30PM GMT
Release Date Price: $4.85 (-9.85%)
Jesse Hawkins
Aegis Capital Corp - Analyst

We have already [done the intro] (technical difficulty) so you can go ahead and get started if you want to pop up your presentation, give a brief little background on yourself. Please, the floor is yours.

Ordan Trabelsi
SuperCom - President and CEO

Alright. Thanks a lot, and sorry for the delay, guys. My name is Ordan Trabelsi, I'm the CEO and President of SuperCom, and I'm happy to give a corporate update on how things have been going on lately. Then I'll share the screen here -- one second -- alright. You guys can see it?

Jesse Hawkins
Aegis Capital Corp - Analyst

Looks great.

Ordan Trabelsi
SuperCom - President and CEO

Alright, great. Thanks again for joining everyone. We'll run through our corporate presentation of dated February 2022. Safe Harbor statement. So, SuperCom, since 1988 have been a global provider of electronic security solutions to governments around the world, including biometric identification, passports,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot